Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Manuel Fresno is active.

Publication


Featured researches published by Manuel Fresno.


Progress in Neurobiology | 1998

The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system

Ma Ángeles Muñoz-Fernández; Manuel Fresno

Proinflammatory cytokines, tumour necrosis factor (TNF)-alpha, interferon (IFN)-gamma and interleukin (IL)-6, have multiple effects in the central nervous system (CNS) not strictly cytotoxic being involved in controlling neuronal and glial activation, proliferation, differentiation and survival, thus influencing neuronal and glial plasticity, degeneration as well as development and regeneration of the nervous system. Moreover, they can contribute to CNS disorders, including multiple sclerosis. Alzheimers disease and human immunodeficiency virus-associated dementia complex. Recent results with deficient mice in the expression of those cytokines indicate that they are in general more sensible to insults resulting in neural damage. Some of the actions induced by TNF-alpha, and IFN-gamma, including both beneficial and detrimental, are mediated by inducible nitric oxide synthase (iNOS)-derived nitric oxide (NO) production. NO produced by iNOS may be beneficial by promoting the differentiation and survival of neurons. IL-6 does not induce iNOS, explaining why this cytokine is less often involved in this dual role protection pathology. Some of the proinflammatory as well as the neurotrophic effects of those cytokines also involve upregulation of cell adhesion molecules (CAM). Those apparently conflicting results may be reconciled considering that proinflammatory cytokines are involved in promoting the disease, mostly by inducing expression of CAM leading to alteration of the blood-brain barrier integrity, whereas they have a protective role once disease is established due to its immunosuppressive or neurotrophic role. Understanding the dichotomy pathogenesis/neuroprotection of those cytokines may provide a rationale for better therapeutic strategies.


Journal of Biological Chemistry | 2000

An Essential Role of the Nuclear Factor of Activated T Cells in the Regulation of the Expression of the Cyclooxygenase-2 Gene in Human T Lymphocytes

Miguel A. Iñiguez; Sara Martínez-Martínez; Carmen Punzón; Juan Miguel Redondo; Manuel Fresno

We have previously reported that transcriptional induction of cyclooxygenase-2 (COX-2) isoenzyme occurs early after T cell receptor triggering, suggesting functional implications of cyclooxygenase activity in this process. Here, we identify the cis-acting elements responsible for the transcriptional activation of this gene in human T lymphocytes. COX-2 promoter activity was induced upon T cell activation both in primary resting T lymphocytes and in Jurkat cells. This induction was abrogated by inhibition of calcineurin phosphatase with the immunosuppressive drug cyclosporin A, whereas expression of an active calcineurin catalytic subunit enhanced COX-2 transcriptional activation. Moreover, cotransfection of nuclear factor of activated T cells (NFAT) wild type protein transactivated COX-2 promoter activity. Conversely, dominant negative mutants of NFATc or c-Jun proteins inhibited COX-2 induction. Electrophoretic mobility shift assays and site-directed mutagenesis allowed the identification of two regions of DNA located in the positions −117 and −58 relative to the transcriptional start site that serves as NFAT recognition sequences. These results emphasize the central role that the Ca2+/calcineurin pathway plays in COX-2 transcriptional regulation in T lymphocytes pointing to NFAT/activator protein-1 transcription factors as essential for COX-2 promoter regulation in these cells.


Immunology Letters | 1992

Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism

Marı́a Angeles Muñoz-Fernández; Monica A. Fernández; Manuel Fresno

Abstract The protozoan parasite Trypanosoma cruzi is able to replicate in the cytoplasm of primary resident macrophages, but is killed by activated macrophages. Pretreatment of human macrophages with recombinant IFN-γ and to a lesser extent with TNF-α, induced a significant trypanocidal activity. Furthermore, TNF-α had a synergistic effect with IFN-γ on macrophage activation in T. cruzi killing. Similarly, IFN-γ triggered the production of nitric oxide (NO) by macrophages, whereas TNF-α was less effective, although it was also synergistic with IFN-γ. Both NO production and trypanocidal activity, but not superoxide (O 2 − ) generation, induced in macrophages by TNF-α or IFN-γ alone or in combination, were inhibited by N- monomethyl- l -arginine (N-MMLA), a competitive inhibitor of NO synthase activity. Furthermore, a strong correlation was found between the levels of NO production and trypanocidal activity induced by different lymphokine preparations. These results suggest that IFN-γ and TNF-α are involved in the activation of the trypanocidal activity of human macrophages through a NO-dependent mechanism.


Immunology Today | 1997

Cytokines and infectious diseases

Manuel Fresno; Manfred Kopf; Luis Rivas

Abstract Knowledge of the cytokine response to infections diseases is important in understanding the immunological basis of host resistance as well as pathogenesis, and is useful in the analysis of mechanisms underlying the differentiation of polarized T-cell-dependent immune function. These issues were addressed at a recent workshop ∗ ∗The Juan March Workshop on ‘Cytokines in Infectious Diseases was held at Madrid, Spain, on 3–5 June 1996..


Trends in Parasitology | 2003

Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?

Núria Gironès; Manuel Fresno

In Chagas disease, caused by Trypanosoma cruzi, the scarcity of parasites in the chronic phase of the disease contrasts with the severe cardiac pathology observed in ∼30% of chronic patients, and suggests a role for autoimmunity as the origin of the pathology. Recent studies on parasite detection, however, suggest that parasite persistence is the main cause of Chagas disease. To date, there is no conclusive evidence for the pathogenic role of either autoimmunity or parasite-specific immunity. Here, the most recent evidence in favour of each hypothesis is discussed.


Clinical and Vaccine Immunology | 2002

Cytokines in the Pathogenesis of and Protection against Malaria

Iñigo Angulo; Manuel Fresno

Malaria is caused by the protozoan Plasmodium , transmitted to humans by Anopheles mosquitoes. The most dangerous of the plasmodia infecting humans is Plasmodium falciparum . Most of the clinical signs of this disease are caused by the parasite at stages in which it multiplies asexually in red blood


Current Topics in Microbiology and Immunology | 2005

Trypanosoma cruzi-Induced Molecular Mimicry and Chagas' Disease

Núria Gironès; Henar Cuervo; Manuel Fresno

Chagas disease, caused by Trypanosoma cruzi, has been considered a paradigm of infection-induced autoimmune disease. Thus, the scarcity of parasites in the chronic phase of the disease contrasts with the severe cardiac pathology observed in approximately 30% of chronic patients and suggested a role for autoimmunity as the origin of the pathology. Antigen-specific and antigen-non-specific mechanisms have been described by which T. cruzi infection might activate T and B cells, leading to autoimmunity. Among the first mechanisms, molecular mimicry has been claimed as the most important mechanism leading to autoimmunity and pathology in the chronic phase of this disease. In this regard, various T. cruzi antigens, such as B13, cruzipain and Cha, cross-react with host antigens at the B or T cell level and their role in pathogenesis has been widely studied. Immunization with those antigens and/or passive transfer of autoreactive T lymphocytes in mice lead to clinical disturbances similar to those found in Chagas disease patients. On the other hand, the parasite is becoming increasingly detected in chronically infected hosts and may also be the cause of pathology either directly or through parasite-specific mediated inflammatory responses. Thus, the issue of autoimmunity versus parasite persistence as the cause of Chagas disease pathology is hotly debated among many researchers in the field. We critically review here the evidence in favor of and against autoimmunity through molecular mimicry as responsible for Chagas disease pathology from clinical, pathological and immunological perspectives.


European Journal of Immunology | 2000

Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring.

Laura Giordanengo; Cristina A. Maldonado; Héctor Walter Rivarola; Daniel Iosa; Núria Gironès; Manuel Fresno; Susana Gea

Human and murine infection with Trypanosoma cruzi parasite is usually accompanied by strong humoral and cellular immune response to cruzipain, a parasite immunodominant antigen. In the present study we report that the immunization of mice with cruzipain devoid of enzymatic activity, was able to induce antibodies which bind to a 223‐kDa antigen from a mouse heart extract. We identified this protein as the mouse cardiac myosin heavy chain by sequencing analysis. The study of IgG isotype profile revealed the occurrence of all IgG isotypes against cruzipain and myosin. IgG1 showed the strongest reactivity against cruzipain, whereas IgG2a was the main isotype against myosin. Anti‐cruzipain antibodies purified by immunoabsorption recognized the cardiac myosin heavy chain, suggesting cross‐reactive epitopes between cruzipain and myosin. Autoimmune response in mice immunized with cruzipain was associated to heart conduction disturbances. In addition, ultrastructural findings revealed severe alterations of cardiomyocytes and IgG deposit on heart tissue of immunized mice. We investigated whether antibodies induced by cruzipain transferred from immunized mothers to their offsprings could alter the heart function in the pups. All IgG isotypes against cruzipain derived from transplacental crossing were detected in pups sera. Electrocardiographic studies performed in the offsprings born to immunized mothers revealed conduction abnormalities. These results provide strong evidence for a pathogenic role of autoimmune response induced by a purified T. cruzi antigen in the development of experimental Chagas disease.


Journal of Immunology | 2006

ERK5 Activates NF-κB in Leukemic T Cells and Is Essential for Their Growth In Vivo

Johan Garaude; Seyma Cherni; Sandra Kaminski; Etienne Delepine; Christine Chable-Bessia; Monsef Benkirane; Joana Borges; Atanasio Pandiella; Miguel A. Iñiguez; Manuel Fresno; Robert A. Hipskind; Martin Villalba

MAPK cascades play a central role in the cellular response to the environment. The pathway involving the MAPK ERK5 mediates growth factor- and stress-induced intracellular signaling that controls proliferation or survival depending upon the cell context. In this study, we show that reducing ERK5 levels with a specific small hairpin RNA 5 (shERK5) reduced cell viability, sensitized cells to death receptor-induced apoptosis, and blocked the palliative effects of phorbol ester in anti-Fas Ab-treated cells. shERK5 decreased nuclear accumulation of the NF-κB p65 subunit, and conversely, ectopic activation of ERK5 led to constitutive nuclear localization of p65 and increased its ability to trans activate specific reporter genes. Finally, the T lymphoma cell line EL-4, upon expression of shERK5, proliferated in vitro, but failed to induce s.c. tumors in mice. Our results suggest that ERK5 is essential for survival of leukemic T cells in vivo, and thus represents a promising target for therapeutic intervention in this type of malignancy.


Journal of Immunology | 2006

NF-κB-Inducing Kinase Is Involved in the Activation of the CD28 Responsive Element through Phosphorylation of c-Rel and Regulation of Its Transactivating Activity

Carmen Sánchez-Valdepeñas; Angel Martín; Parameswaran Ramakrishnan; David Wallach; Manuel Fresno

Previous evidence suggested that NF-κB-inducing kinase (NIK) might regulate IL-2 synthesis. However, the molecular mechanism is not understood. In this study, we show that NIK is involved in CD3 plus CD28 activation of IL-2 transcription. Splenic T cells from aly/aly mice (that have a defective NIK protein) have a severe impairment in IL-2 and GM-CSF but not TNF secretion in response to CD3/CD28. This effect takes place at the transcriptional level as overexpression of alyNIK inhibits IL-2 promoter transcription. NIK activates the CD28 responsive element (CD28RE) of the IL-2 promoter and strongly synergizes with c-Rel in this activity. We found that NIK interacts with the N-terminal domain of c-Rel, mapping this interaction to aa 771–947 of NIK. Moreover, NIK phosphorylates the c-Rel C-terminal transactivation domain (TAD) and induces Gal4-c-Rel-transactivating activity. Anti-CD28 activated Gal4-c-Rel transactivation activity, and this effect was inhibited by a NIK-defective mutant. Deletion studies mapped the region of c-Rel responsive to NIK in aa 456–540. Mutation of several serines, including Ser471, in the TAD of c-Rel abrogated the NIK-enhancing activity of its transactivating activity. Interestingly, a Jurkat mutant cell line that expresses one of the mutations of c-Rel (Ser471Asn) has a severe defect in IL-2 and CD28RE-dependent transcription in response to CD3/CD28 or to NIK. Our results support that NIK may be controlling CD28RE-dependent transcription and T cell activation by modulating c-Rel phosphorylation of the TAD. This leads to more efficient transactivation of genes which are dependent on CD28RE sites where c-Rel binds such as the IL-2 promoter.

Collaboration


Dive into the Manuel Fresno's collaboration.

Top Co-Authors

Avatar

Núria Gironès

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Juan Miguel Redondo

Centro Nacional de Investigaciones Cardiovasculares

View shared research outputs
Top Co-Authors

Avatar

Carmen Punzón

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Henar Cuervo

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Miguel A. Iñiguez

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Pilar Alcaide

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Javier Carrión

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Eva Cano

Instituto de Salud Carlos III

View shared research outputs
Researchain Logo
Decentralizing Knowledge